- Abstract Number: 2093
Hazard Index Equations Using Data Collected at Baseline and After One Year Treatment Allow Early Prediction of Poor Outcome in an Incident Lupus Nephritis Population: Data from the Louvain Lupus Nephritis Cohort
- Abstract Number: 1381
Health Related Quality of Life in Children with Systemic Lupus Erythematosus
- Abstract Number: 0058
Health System Improvement in Inpatient ANA and Serologic Test Utilization
- Abstract Number: 2070
Health-Related Quality of Life Across the Spectrum of Connective Tissue Diseases: A Latent Profile Analysis
- Abstract Number: 1798
Health-Related Quality of Life Improvements Resulting from a Treat-to-Target Strategy in the Management of Gout: Post- Hoc Analysis of a Multicenter, Randomized, Double-Blind, Non-Inferiority Trial
- Abstract Number: 0059
Healthcare Resource Utilization and Costs of Management of Lupus Nephritis in Adult and Juvenile Patients with Systemic Lupus Erythematosus
- Abstract Number: 2006
Healthcare Resource Utilization and Economic Burden of Patients with Adequate and Inadequate Responses to Advanced Therapies for Rheumatoid Arthritis in Japan
- Abstract Number: 1818
Hepatic Steatosis and Fibrosis in Patients with Gout Detected by Elastography
- Abstract Number: 1864
Hepatitis B Exposure and Infection in Idiopathic Inflammatory Myopathies: Prevalence, Presentation, and Treatment Response
- Abstract Number: 1403
Herpes Zoster in Rheumatoid Arthritis: Prospective Single University Center Study
- Abstract Number: 0555
Heterogeneity in Origin and Function of Distinct Human Synovial-tissue Dendritic Cells in Health, Active Rheumatoid Arthritis (RA) and RA in Disease Remission
- Abstract Number: 0769
Heterologous Vector versus Homologous mRNA COVID-19 Booster Vaccination in Non-seroconverted Immunosuppressed Patients: A Randomized Controlled Trial
- Abstract Number: 2123
Hierarchical Ranking of Biologic Disease-Modifying Antirheumatic Drugs and Targeted Systemic Therapies for Psoriatic Arthritis: A Network Meta-analysis
- Abstract Number: 0257
High Density Lipoprotein Bound miR-1246 Is Enriched in Patients with Rheumatoid Arthritis and Is Proinflammatory
- Abstract Number: 1801
High Frequency of Structural Damage in the Lower Spine of Patients with Chondrocalcinosis
- Abstract Number: 1109
High Interleukin-13 Level Is Associated with Disease Stability in Interstitial Lung Disease
- Abstract Number: 0964
High Rates of Fetal Growth Restriction in Systemic Lupus Erythematosus Pregnancies
- Abstract Number: 0807
High Throughput Analyses for the Study of Synovial Tissue Biopsy from Inflammatory Arthritis Patients
- Abstract Number: 1490
High Throughput Transcriptomic Analysis of Peripheral Mononuclear Cells Identifies Molecular Alterations Associated with the Active Clinical Phenotype of Axial Spondyloarthritis
- Abstract Number: 1701
High TNFAIP3-Transfected Cell Activity: An In Vitro Model for Phagocyte Study of Monogenic Behçet’s Disease Pathophysiology
- Abstract Number: 0563
High-Dimensional Immunophenotyping with Mass Cytometry Reveals Unique Immune Cell Aberrations in Patients with Undiagnosed Inflammatory and Autoimmune Diseases
- Abstract Number: 0310
Higher Baseline Circulating CD4+CXCR5+PD-1hi Follicular Helper T Cells Predict Therapeutic Efficacy of Abatacept in Moderate to Severe Rheumatoid Arthritis
- Abstract Number: 0449
Higher Disease Acuity at Presentation and Increased Lower Respiratory Involvement in Hispanic and Black Patients with ANCA-Associated Vasculitis
- Abstract Number: 2252
Higher Matrix Metalloproteinase Levels Are Predictive of Incident Interstitial Lung Disease Among a Cohort of US Veterans with Rheumatoid Arthritis
- Abstract Number: 1181
Hippo Pathway Effectors Promote and Maintain Myofibroblast Differentiation and Endothelial-to-mesenchymal Transition in Systemic Sclerosis
- Abstract Number: 1885
Histopathological Patterns of Muscle Involvement and Clinical Correlations in a Retrospective Cohort of Scleroderma Patients
- Abstract Number: 1299
Hitting the Target Together: Supporting Shared Decision-Making with Juvenile Idiopathic Arthritis (JIA) Patients Followed in the Out-Patient Rheumatology Setting at the Hospital for Sick Children
- Abstract Number: 0774
HLA-DQ2 Is Associated with Anti-drug Antibody Formation to Infliximab Across Immune-mediated Inflammatory Diseases
- Abstract Number: 0743
Home-Based Telehealth in Rheumatology: A Systematic Review & Narrative Synthesis
- Abstract Number: 1871
Hospitalization Outcomes for Acute Myocardial Infraction and Acute Heart Failure in Patients with Idiopathic Inflammatory Myopathies (IIM) from 2016-2019 National Inpatient Sample (NIS)
- Abstract Number: PP10
How Advocating for My Autoimmune Disease Led Me to Desire to Pursue a Career in Rheumatology
- Abstract Number: PP13
How Becoming Engaged in My Care with Specialized Tools and Support Helped Me Find My Personal Lupus Triggers and Regain Control of My Health
- Abstract Number: 1368
How Common Is the Coexistence of Juvenile Localized and Systemic Scleroderma? Results of a Multination Survey
- Abstract Number: 2198
How Did a Mandatory Switching Policy for Biosimilars in Canada Impact Uptake and Spending?
- Abstract Number: 1516
How Disease Activity Can Affect Workability in Spondyloarthropaties: A Monocentric Cohort Analysis
- Abstract Number: 1495
How Does Body Mass Index Affect Secukinumab Treatment Outcomes and Safety in Patients with Ankylosing Spondylitis? – Real World Data from a German Observational Study
- Abstract Number: 0395
How Does Body Mass Index Affect Secukinumab Treatment Outcomes and Safety in Patients with Psoriatic Arthritis? – Real World Data from a German Observational Study
- Abstract Number: 1028
How Does PsAID Implementation Affect Treatment Intensification and Patient Satisfaction in PsA?
- Abstract Number: 1497
How Does Time to Diagnosis and Gender Affect Treatment Outcomes in Patients with Ankylosing Spondylitis or Psoriatic Arthritis? – Real World Data from a German Observational Study with Secukinumab
- Abstract Number: 1288
How Often Do We Provide Relevant and Patient Centric Discharge Instructions in Rheumatology? A Single Academic Center Clinic Experience
- Abstract Number: 2141
How Well Does Ultrasound-assessed Synovitis in Reduced Joint Sets Predict the Response to Secukinumab in Patients with Active Psoriatic Arthritis and Inadequate Response to Conventional DMARDs? – Exploratory Results from a Phase 3b Study
- Abstract Number: 0666
HRES-1/Rab4 Controls the Overexpression of CD38 and Depletion of IL-2 in CD4+ T Cells; Potential Involvement in Proinflammatory Lineage Development in SLE
- Abstract Number: 0786
Humoral and T-cell Responses to SARS-CoV-2 Vaccination in Patients with Rheumatoid Arthritis
- Abstract Number: 0753
Humoral Immune Response Against BNT162b2 mRNA COVID-19 Vaccine in Patients with Rheumatic Disease Undergoing Immunosuppressive Therapy: A Japanese Monocentric Study
- Abstract Number: 0785
Humoral Immune Responses Following Four SARS-CoV-2 Vaccine Doses or COVID-19 Infection in Patients with Immune-Mediated Inflammatory Diseases on Immunosuppressive Therapy: A Prospective Cohort Study
- Abstract Number: 1604
Hydroxychloroquine Does Not Prevent the Future Development of Rheumatoid Arthritis in a Population with Baseline High Levels of Antibodies to Citrullinated Protein Antigens and Absence of Inflammatory Arthritis: Interim Analysis of the StopRA Trial
- Abstract Number: 1654
Hydroxychloroquine Dosing Less Than 5 Mg/kg/day Leads to Increased Hospitalizations for Systemic Lupus Erythematosus Flares
- Abstract Number: 0983
Hydroxychloroquine Use and Heart Failure with Preserved Ejection Fraction in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
- Abstract Number: 0815
Hyper-IgG4 in Patients with Systemic Autoinflammatory Disease
ACR Convergence 2022
November 10-14, 2022. Philadelphia, PA.